Literature DB >> 8136895

Neuropsychological heterogeneity in mild Alzheimer's disease.

G Binetti1, E Magni, A Padovani, S F Cappa, A Bianchetti, M Trabucchi.   

Abstract

In order to investigate neuropsychological differences in patients with mild AD, we carried out a pilot study on 28 patients with a clinical diagnosis of mild dementia (CDR: 0.5-1) using an extensive neuropsychological battery, in comparison with 28 normal controls. The results of a cluster analysis, applied on the neuropsychological variables, showed the existence of at least two main subgroups of patients. Cluster 1 patients had a mean age of 61.1 years and showed a greater impairment on measures of language, abstract reasoning and verbal fluency; cluster 2 patients, with a mean age of 72.0, had more severe impairment in memory function. These preliminary results may suggest the existence of different subtypes of AD characterized by selective neuropsychological deterioration in the early stages of the disease.

Entities:  

Mesh:

Year:  1993        PMID: 8136895     DOI: 10.1159/000107340

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  14 in total

1.  Functional connectivity changes differ in early and late-onset Alzheimer's disease.

Authors:  Natalina Gour; Olivier Felician; Mira Didic; Lejla Koric; Claude Gueriot; Valérie Chanoine; Sylviane Confort-Gouny; Maxime Guye; Mathieu Ceccaldi; Jean Philippe Ranjeva
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

2.  Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Authors:  Natalie C Kaiser; Rebecca J Melrose; Collin Liu; David L Sultzer; Elvira Jimenez; Michael Su; Lorena Monserratt; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-09-17       Impact factor: 2.035

3.  Radial width of the temporal horn: a sensitive measure in Alzheimer disease.

Authors:  Giovanni B Frisoni; Cristina Geroldi; Alberto Beltramello; Angelo Bianchetti; Giuliano Binetti; Giovanni Bordiga; Charles DeCarli; Mikko P Laakso; Hilkka Soininen; Cristina Testa; Orazio Zanetti; Marco Trabucchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

4.  Executive dysfunction in early Alzheimer's disease.

Authors:  G Binetti; E Magni; A Padovani; S F Cappa; A Bianchetti; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

5.  Measures of medial temporal lobe atrophy in Alzheimer's disease.

Authors:  G B Frisoni; A Bianchetti; C Geroldi; M Trabucchi; A Beltramello; C Weiss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

6.  Temporal lobe asymmetry in patients with Alzheimer's disease with delusions.

Authors:  C Geroldi; N M Akkawi; S Galluzzi; M Ubezio; G Binetti; O Zanetti; M Trabucchi; G B Frisoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

7.  Brain atrophy in frontotemporal dementia.

Authors:  G B Frisoni; A Beltramello; C Geroldi; C Weiss; A Bianchetti; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

8.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

9.  Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Authors:  Meredith L Phillips; Eddie C Stage; Kathleen A Lane; Sujuan Gao; Shannon L Risacher; Naira Goukasian; Andrew J Saykin; Maria C Carrillo; Bradford C Dickerson; Gil D Rabinovici; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2020-01-03       Impact factor: 2.959

10.  Should EOAD patients be included in clinical trials?

Authors:  Kinga Szigeti; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2011-02-08       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.